Germline mutation of the BRCA2 gene causes a high risk of developing breast and ovarian cancer. Although the BRCA2 protein has been implicated in homologous recombination (HR) of DNA and in transcription, it is still unclear how mutation leads to tumorigenesis. We have identi®ed a nonmammalian homologue of BRCA2 from chicken, which encodes a protein with 3397 amino acids (aa) and shows only 40% identity to human BRCA2. However, comparison of the mammalian and chicken sequences revealed remarkably high homology in several segments. These include a Nterminal region (*100 aa), which was previously shown to possess intrinsic transcriptional activity, and a C-terminal region (aa residue *2480-*3180 in human BRCA2), which has not been clearly assigned any function. In contrast, although the eight BRC repeats of mammalian BRCA2 are believed to play an important role in HR by interacting with Rad51, the BRC3, BRC5, and BRC6 repeats exhibit virtually no similarity to their mammalian counterparts. Among 311 missense mutations listed as unclassi®ed variants in the NIH Breast Cancer Information Core database, only 83 of these sites are identical in chicken BRCA2. Thus, chicken BRCA2 may provide a means to identify domains and residues associated with cancer predisposition.
Introduction
Germline mutation of the BRCA2 gene carries a high risk of developing breast, ovarian, and pancreas cancer (Scully and Livingston, 2000; Zheng et al., 2000) .
Patients from aicted families have mutations in one allele of the gene, and tumors arising in these patients invariably exhibit loss of the other intact copy of the gene (loss of heterozygosity). Therefore, the BRCA2 protein is considered to have a tumor suppressor function. Human BRCA2 is a large protein of 3418 amino acids (aa), having no similarity to known proteins and no apparent homologues in yeast,¯ies, and worms. The BRCA2 gene is widely expressed in actively dividing tissues including the epithelium of the breast during puberty and pregnancy (Rajan et al., 1997) . Mice with targeted disruption of the 5' end of BRCA2 die early in embryonic development, while mice carrying truncated mutations are often viable until birth and exhibit chromosomal instability and increased sensitivity to genotoxic treatments (Connor et al., 1997; Patel et al., 1998) . These observations support the notion that BRCA2 plays a role in maintaining chromosomal DNA and provide a mechanistic basis for its function as a tumor suppressor. Recent studies have focused on BRCA2's role in homologous recombination (HR), one of the two major pathways of DNA double-strand break (DSB) repair (Scully and Livingston, 2000; Zheng et al., 2000; Moynahan et al., 2001) . Rad51, the structural and functional homolog of the E. coli RecA in eukaryotic cells, plays a central role in HR (Baumann and West, 1998; Haber, 1999) and is essential for proliferation of higher eukaryotic cells (Sonoda et al., 1998) , as discussed in Morrison and Takeda (2000) ; Sonoda et al. (2001) ; Thompson and Schild (2001) . BRCA2 directly interacts with human Rad51 protein (Wong et al., 1997; Chen et al., 1998b; Marmorstein et al., 1998; Davies et al., 2001) both in vitro and in vivo. In addition, BRCA2 not only co-localizes with Rad51 in both mitosis and meiosis (Chen et al., 1998a) , but also is required for ecient Rad51 focus formation (Yuan et al., 1999; Yu et al., 2000) . These observations indicate that BRCA2 plays a critical role in HR by associating with Rad51.
Here we report the cloning of the putative homologue of BRCA2 from the chicken, Gallus domesticus. We think that this is likely the ®rst non-mammalian ortholog of the BRCA2 gene because genomic Southern blot analysis at very low stringency using this cDNA as probe revealed that no other hybridizing sequence existed in chicken genome (data not shown). The sequence contains a polyA run and an in-frame stop codon that is located six bp upstream of initiation codon. The sequence was submitted to DDBJ under the accession number AB066374. The isolated chicken BRCA2 cDNA encodes a protein with 3397 aa compared with the 3418 aa human protein. An alignment of the predicted protein sequences from four species (human, mouse, rat, and chicken) was performed using Genetyx-Mac ver.10 (Software Development Co. Ltd, Tokyo, Japan). The aa sequence identities of chicken BRCA2 with that of human, mouse, and rat homologs are 40, 39, and 38%, respectively, whereas the identity between mouse and human BRCA2 is 57% and between mouse and rat is 82% ( Table 1 ). The conservation of BRCA2 is comparable to that of BRCA1, where the aa sequence identity is 33% between chicken and human, and is *60% between rodents and human (Orelli et al., 2001) .
In Figure 1b , results of pair-wise comparison along full length human BRCA2 is shown as per cent identity with chicken BRCA2. This comparison reveals several segments that are highly conserved, including N-terminal and C-terminal portions, and the BRC repeats. The Nterminal portion of aa 1 ± 125 is highly conserved and includes previously identi®ed segments associated with transcriptional inhibiting (aa 1 ± 17) and activating (aa 18 ± 60) activity (Milner et al., 1997) . It is noteworthy that aa residue 42 (tyrosine), which is essential for the activation potential (Milner et al., 1997) , is conserved in all four species. The sequences in exon 3 (aa 23 ± 105 in human BRCA2) were found to be deleted in a breast/ ovarian cancer family, although it is unclear how this deletion causes oncogenesis. Interestingly, a stretch of sequence (aa 176 ± 212 in human BRCA2) located between the transcriptional regulation and P/CAF interacting domains is conserved (indicated by a single asterisk and a line in Figure 1b and c) while no known motif or data regarding the function of this region have been published. In contrast, the adjacent P/CAFinteracting domain (aa 290 ± 453 in human BRCA2) (Fuks et al., 1998) is only modestly conserved between human and chicken (17% identify).
The C-terminal region (aa *2480 ± *3180 in human BRCA2) is highly conserved in the four-species although the function is not known. Furthermore, there is a short conserved region (aa 2222 ± 2243 in human BRCA2), marked in Figure 1b ,c with three asterisks and a line, which was not identi®ed previously because both upstream and downstream regions are relatively well conserved among mammalian BRCA2 proteins. Two proteins were reported to interact with these C-terminal conserved regions. The human DSS1 protein interacts with BRCA2 aa 2472 ± 2957 (Marston et al., 1999) , and the BUBR1 kinase interacts with BRCA2 aa 2861 ± 3176 (Futamura et al., 2000) . DSS1 is one of the three candidate genes on chromosome 7 whose defect may be responsible for a developmental disorder called split hand/split foot malformation (SHFM) (Crackower et al., 1996) . DSS1 is conserved from yeast to human, and may have a function related to cell cycle progression (Marston et al., 1999) . On the other hand, BUBR1 is involved in a mitotic checkpoint and can phosphorylate BRCA2 (Futamura et al., 2000) . The biological signi®cance of this interaction is not clear because no defect in spindle checkpoint is reported in BRCA2-de®cient cells.
A search using PSORT (http://psort.nibb.ac.jp/) revealed several potential nuclear localization signals (NLS) in chicken BRCA2. In human BRCA2, two functional NLS sites were identi®ed in the C-terminal region (Spain et al., 1999) . This result might explain why the vast majority of BRCA2 frameshift or truncating mutations are nonfunctional since they would fail to translocate into the nucleus (Spain et al., 1999) . The relative position of at least one of the NLS (KNCKKRR, aa 3263 ± 3269 in human BRCA2) appears to be conserved in chicken BRCA2 (PRNSKKRK, aa 3209 ± 3216).
Human BRCA2 has an exceptionally large central exon (exon 11) encoding more than 50% of the protein. PCR of chicken genomic DNA con®rmed that the corresponding region is encoded in a single exon (data not shown). Eight conserved repeats, the BRC repeats, were found in exon 11 in human and all other mammalian species examined to date (McAllister et al., 1997; Bignell et al., 1997) . Overall conservation of the BRC repeats between the chicken and mammalian BRCA2 proteins is lower when compared to that of the N-and C-terminal regions, possibly explaining why previous attempts to clone this region in chicken failed (Bignell et al., 1997) . There are only six segments that exhibit relatively high identity in the region that corresponds to that encoded by the human exon 11. These include BRC1, 2, 4, 7, and 8 repeats, and a stretch of 36 aa between BRC1 and BRC2 (corresponding to aa 1103 ± 1138 in human BRCA2, indicated in Figure 1b ,c by two asterisks and a line). This segment is also conserved in the mammalian proteins, but its function is unknown (Bignell et al., 1997) . Conservation of the BRC1 and 2 repeats is in agreement with an important role for these repeats in mouse embryogenesis. Indeed, deletion of the whole exon 11 is lethal to the early embryo while mice carrying a truncation just beyond the C-terminal end of BRC3 are partially viable (Figure 1a ) (Connor et al., 1997; Ludwig et al., 1997; Friedman et al., 1998; Patel et al., 1998) . The BRC3, 5 and 6 repeats are quite diverged from the BRC consensus sequences (Figure 2b ), particularly BRC3, although for 26 aa residues assigned as BRC3, 5 and 6 repeats in human BRCA2 (Bignell et al., 1997) , 17, 15, and 8 aa residues are identical in mouse BRCA2 (as much as 65, 58 and 31% identity), respectively (Figure 2a) . The lack of BRC3 conservation in chicken is somewhat surprising because of the relatively high conservation of between human and mouse BRC3 (65%).
There appear to be a number of segments of BRCA2 that can interact with Rad51 (Bignell et al., 1997; Wong et Marmorstein et al., 1998) , which include BRC repeats and a short region near the C-terminus in mouse BRCA2 (aa 3196 ± 3232) (Mizuta et al., 1997; Sharan et al., 1997) . Biochemical studies showed that every BRC repeat, except for BRC5 and BRC6, can interact with Rad51 as a modular unit (Wong et al., 1997; Chen et al., 1998b) . Also, BRC3 and BRC4 polypeptides can abolish DNA binding and assembly of Rad51 along singlestranded DNA in vitro (Davies et al., 2001 ). These observations indicate that a single BRC polypeptide alone can interact with Rad51. This notion is supported by an in vivo study, where expression of a single BRC repeat (BRC4) disrupted Rad51-BRCA2 complex in a dominant negative manner . These data suggest that BRC repeats have a redundant or overlapping role in binding to Rad51. While some aa residues of BRC1 and BRC4 were shown to be essential for binding of the BRC polypeptides to Rad51 and are conserved between human and chicken (Figure 2a) , the clinical relevance of any mutations in the BRC repeats is not clear at the moment (see discussion below). The putative BRC3 repeat in chicken BRCA2 is Figure 1 Comparison of the aa sequence of chicken and human BRCA2 proteins. To isolate chicken BRCA2 cDNA, we screened a chicken spleen cDNA library (Stratagene, La Jolla, CA, USA) using N-terminal (codon 1 ± 320) and C-terminal (codon 2241 ± 2940) fragments of human BRCA2 cDNA as probes at low stringency hybridization. Clones that contain either N-terminal or Cterminal portion were obtained. The cDNA corresponding to the gap between the N-terminal and C-terminal clones (*6.5 kb) was isolated by long range RT ± PCR. The extreme C-terminal region including polyA tail was obtained by 3'-RACE of cDNAs derived from DT40 cells. To avoid PCR error, we ampli®ed the entire region of the BRCA2 cDNA from normal chicken testis RNA in three overlapping fragments, and performed direct base sequencing with primers that were set approximately every 500 base pairs on both sense and anti-sense orientations. The sequence data was assembled with the aid of Auto-assembler software (Applied Biosystems, Inc., Foster City, CA, USA). Previously reported BRCA2 truncated mutations are shown in (a). The BRC motifs are depicted as grey boxes. After alignment of the BRCA2 sequences from four species using Genetyx-Mac ver.10, % identity of the chicken to human BRCA2 was calculated in every 20 aa window with an overlap of 10 aa along the whole human sequence (b). The horizontal line represents the entire length of human BRCA2. The dot at the right end is derived from data of only 18 aa of the Cterminus of BRCA2. Horizontal bars mark the transcriptional activation domain (TAD), P/CAF interaction domain, DSS1 binding domain, hBUBR binding region, and C-terminal Rad51 interaction domain (Rad). Numbers designate conserved BRC repeats.
Regions that exhibit high conservation without any known function are indicated with asterisks and a line in (b), and their base sequences are shown in (c). Identical aa sequences are boxed
Identification of the chicken BRCA2 homologue M Takata et al likely to be de®cient in interaction with Rad51, since an aa residue (Thr1430 in BRC3 of human BRCA2), which is essential for binding to Rad51 (Davies et al., 2001) , is not conserved in chicken BRCA2. However, chicken BRCA2 may have the same eciency of Rad51 interaction as does mammalian BRCA2 because other BRC repeats may fully substitute for the absence of functional BRC3 in chicken BRCA2. It should be noted that although some BRC repeats are not conserved between human and chicken, the distance between each repeat is precisely conserved, implying that the relative position of BRC repeats in BRCA2 is critical for its function.
In chicken BRCA2, the C-terminal Rad51-binding region identi®ed in mouse retains signi®cant similarity to mouse and human BRCA2 (49 and 51% identity, respectively). A critical role of these C-terminal sequences is suggested by the ®nding that murine embryonic stem cells carrying deletion of the C terminus of the BRCA2 gene (aa 3089 ± 3329 in one allele and 3140 ± 3329 in another) exhibited elevated sensitivity to ionizing radiation (Morimatsu et al., 1998) and HR defects demonstrated by gene targeting and chromosomal gene conversion experiments (Moynahan et al., 2001) . Deletion of a nuclear localization signal (aa 3186 ± 3192 in mouse) might be an alternative explanation of this phenotype. However, predominantly nuclear localization of this C-terminally truncated BRCA2 protein is demonstrated in those cells, suggesting that another NLS is located more Nterminal in mouse BRCA2 (Moynahan et al., 2001) .
Since its discovery (Wooster et al., 1995; Tavtigian et al., 1996) , hundreds of sequence variations in human BRCA2 gene have been found in tumors as well as in normal tissues. Approximately 68% were truncating mutations, which can be assumed to be pathogenic, whereas 32% were aa changes that are either neutral polymorphisms or cancer-causing missense mutations (Wagner et al., 1999) . Even if a particular aa change is found only in a patient of familial breast/ovarian cancer, one cannot readily conclude that this change is a true disease-causing mutation without demonstrating its impact on BRCA2's function in vivo. This is not an easy task, since there are only few cell lines available from tumors carrying mutations in the BRCA2 gene, and embryonic ®broblast cells from mice with BRCA2 truncating mutations have a defect in proliferation (Connor et al., 1997; Patel et al., 1998) . These cells possibly have other uncharacterized mutations because of genomic instability caused by defective BRCA2. Furthermore, overexpression of BRCA2 in murine cells under the control of a strong constitutive promoter appears to be toxic (AR Venkitaraman, personal communication). Thus, although the NIH database contains 311 BRCA2 aa changes seen in patients and families, many of them are listed as unclassi®ed variants. Among the 311 changes, 156 sites are conserved in both mouse and rat, whereas only 83 are conserved in chicken as well. This low conservation suggests that most of the 311 changes are not necessarily associated with tumorigenesis. Also, the chicken BRCA2 sequence could provide a means to determine which variants should be examined for defective function. Alignment of the BRC repeats from chicken, human, mouse, and rat BRCA2. (a) Each BRC repeat alignment is a part of the overall alignment made by Genetix-Mac of the full length sequences. Each BRC repeat is de®ned as a stretch of 26 aa sequences in human BRCA2 (Bignell et al., 1997; McAllister et al., 1997) . Residues that match in all four species, or in three species, are in black and shaded boxes, respectively. Known critical residues for Rad51 binding in BRC1 and BRC4 repeats are indicated with asterisks . (b) BRC repeats of chicken BRCA2 are compared with the consensus sequences of the mammalian BRC repeat. Residues that are identical with the consensus sequences are shown in black
